重组人骨形态发生蛋白-2（rhBMP-2）在颌面部创伤中的应用。
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma.
作者信息
Herford A S
机构信息
Department of Oral and Maxillofacial Surgery, Loma Linda University, Loma Linda, CA, USA.
出版信息
Chin J Traumatol. 2017 Feb;20(1):1-3. doi: 10.1016/j.cjtee.2016.05.004. Epub 2017 Feb 9.
Abstract
In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.
摘要
近年来，重组人骨形态发生蛋白-2（rhBMP-2）已被作为一种治疗选择用于治疗多种先天性和后天性颅面缺损。尽管已有令人鼓舞的临床结果，但国际文献仍缺乏完整的指南，包括rhBMP-2的使用限制和适应证。本文讨论了rhBMP-2在面部创伤患者中的可能适应证。
相似文献
1
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma.
Chin J Traumatol. 2017 Feb;20(1):1-3. doi: 10.1016/j.cjtee.2016.05.004. Epub 2017 Feb 9.
2
Scientific evidence on the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in oral and maxillofacial surgery.
Oral Maxillofac Surg. 2016 Sep;20(3):223-32. doi: 10.1007/s10006-016-0563-4. Epub 2016 May 29.
3
Clinical applications of rhBMP-2 in maxillofacial surgery.
J Calif Dent Assoc. 2007 May;35(5):335-41.
4
Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics.
J Mater Sci Mater Med. 2016 Dec;27(12):184. doi: 10.1007/s10856-016-5800-8. Epub 2016 Oct 27.
5
Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.
J Clin Periodontol. 2013 Jul;40(7):688-97. doi: 10.1111/jcpe.12109. Epub 2013 Apr 30.
6
Antigen-extracted xenogeneic cancellous bone graft with recombinant human bone morphogenetic protein-2 enhances bone regeneration in repair of mandibular defect in rabbits.
Kaohsiung J Med Sci. 2015 Jan;31(1):18-25. doi: 10.1016/j.kjms.2014.10.008. Epub 2014 Nov 21.
7
Biomechanical Integrity in Craniofacial Surgery: Calvarial Reconstruction in Favorable and Infected Defects with Bone Morphogenetic Protein 2.
Plast Reconstr Surg. 2017 May;139(5):1141-1150. doi: 10.1097/PRS.0000000000003261.
8
Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.
J Clin Periodontol. 2014 Aug;41(8):827-36. doi: 10.1111/jcpe.12270. Epub 2014 Jun 9.
9
Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2).
Curr Med Res Opin. 2006;22 Suppl 1:S1-5. doi: 10.1185/030079906X80567.
10
Efficacy of rhBMP-2 in Cleft Lip and Palate Defects: Systematic Review and Meta-analysis.
Calcif Tissue Int. 2019 Feb;104(2):115-129. doi: 10.1007/s00223-018-0486-1. Epub 2018 Oct 26.
引用本文的文献
1
Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering.
Cell Transplant. 2024 Jan-Dec;33:9636897241276733. doi: 10.1177/09636897241276733.
2
Application of BMP-2 and its gene delivery vehicles in dentistry.
Saudi Dent J. 2024 Jun;36(6):855-862. doi: 10.1016/j.sdentj.2024.03.015. Epub 2024 Mar 22.
3
Does Bone Morphogenetic Protein Use Reduce Pseudarthrosis Rates in Single-Level Transforaminal Lumbar Interbody Fusion Surgeries?
Int J Spine Surg. 2024 May 6;18(2):207-216. doi: 10.14444/8590.
4
Current Status of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Maxillofacial Surgery: Should It Be Continued?
Bioengineering (Basel). 2023 Aug 24;10(9):1005. doi: 10.3390/bioengineering10091005.
5
The current regenerative medicine approaches of craniofacial diseases: A narrative review.
Front Cell Dev Biol. 2023 Feb 28;11:1112378. doi: 10.3389/fcell.2023.1112378. eCollection 2023.
6
Age-Related Low Bone Mineral Density in C57BL/6 Mice Is Reflective of Aberrant Bone Morphogenetic Protein-2 Signaling Observed in Human Patients Diagnosed with Osteoporosis.
Int J Mol Sci. 2022 Sep 23;23(19):11205. doi: 10.3390/ijms231911205.
7
Metabolic Bone Diseases and New Drug Developments.
Biomol Ther (Seoul). 2022 Jul 1;30(4):309-319. doi: 10.4062/biomolther.2022.007. Epub 2022 Mar 28.
8
Periodontal Tissue as a Biomaterial for Hard-Tissue Regeneration following Gene Transfer.
Materials (Basel). 2022 Jan 27;15(3):993. doi: 10.3390/ma15030993.
9
Effects of BMP-2 compound with fibrin on osteoporotic vertebral fracture healing in rats.
J Musculoskelet Neuronal Interact. 2021 Mar 1;21(1):149-156.
10
Bone Morphogenetic Protein-2 in Development and Bone Homeostasis.
J Dev Biol. 2020 Sep 13;8(3):19. doi: 10.3390/jdb8030019.
本文引用的文献
1
Deaths: Leading Causes for 2012.
Natl Vital Stat Rep. 2015 Aug 31;64(10):1-93.
2
Effects of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in grade III open tibia fractures treated with unreamed nails-A clinical and health-economic analysis.
Injury. 2015 Nov;46(11):2267-72. doi: 10.1016/j.injury.2015.07.013. Epub 2015 Aug 13.
3
Bone regenerative efficacy of biphasic calcium phosphate collagen composite as a carrier of rhBMP-2.
Clin Oral Implants Res. 2016 Nov;27(11):e91-e99. doi: 10.1111/clr.12568. Epub 2015 Feb 12.
4
Recombinant human bone morphogenetic protein-2 promote and stabilize hard and soft tissue healing for large mandibular new bone reconstruction defects.
J Craniofac Surg. 2014 May;25(3):860-2. doi: 10.1097/SCS.0000000000000830.
5
Treatment of severe frontobasilar fractures in growing patients: a case series evaluation.
Chin J Traumatol. 2013;16(4):199-203.
6
Immediate distraction osteogenesis: the sandwich technique in combination with rhBMP-2 for anterior maxillary and mandibular defects.
J Craniofac Surg. 2013 Jul;24(4):1383-7. doi: 10.1097/SCS.0b013e318292c2ce.
7
Epidemiology of traumatic head injury in children and adolescents in a major trauma center in Saudi Arabia: implications for injury prevention.
Ann Saudi Med. 2013 Jan-Feb;33(1):52-6. doi: 10.5144/0256-4947.2013.52.
8
Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model.
PLoS One. 2012;7(11):e50378. doi: 10.1371/journal.pone.0050378. Epub 2012 Nov 21.
9
Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw.
J Craniofac Surg. 2012 May;23(3):784-8. doi: 10.1097/SCS.0b013e31824dbdd4.
10
Pediatric facial fractures and potential long-term growth disturbances.
Craniomaxillofac Trauma Reconstr. 2011 Mar;4(1):43-52. doi: 10.1055/s-0031-1272901.
Zotero 插件